4.96
0.03 (0.51%)
| Previous Close | 4.93 |
| Open | 4.97 |
| Volume | 10,064 |
| Avg. Volume (3M) | 7,003 |
| Market Cap | 28,348,298 |
| 52 Weeks Range | |
| Earnings Date | 7 Aug 2023 - 11 Aug 2023 |
| Profit Margin | -21.93% |
| Operating Margin (TTM) | -19.01% |
| Diluted EPS (TTM) | -0.510 |
| Quarterly Revenue Growth (YOY) | -14.60% |
| Total Debt/Equity (MRQ) | 32.54% |
| Current Ratio (MRQ) | 1.60 |
| Return on Assets (TTM) | -16.24% |
| Return on Equity (TTM) | -61.33% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Bullish |
| Diagnostics & Research (Global) | Mixed | Bullish | |
| Stock | Psychemedics Corporation | - | - |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | NA |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | -0.50 |
|
Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. They provide testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples. Geographically it generates the majority of its revenue from the United States. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Small Value |
| % Held by Insiders | 23.14% |
| % Held by Institutions | 20.22% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |